argenx
@argenxglobal
argenx is a global immunology company translating immunology breakthroughs into a world-class portfolio of novel antibody-based medicines.
04-01-2021 00:59:19
444 Tweets
995 Followers
187 Following
Co-creation is key to our work to support the rare disease community. CEO Tim Van Hauwermeiren shares how relationships with disease biology experts and patients drive this work.
Learn more about how we deliver immunology solutions to the patient community.
#TogetherWeDiscover